Skip to Main content Skip to Navigation
Journal articles

[Survey on HIV, HBV and HCV screening practices in cancerology, France]

Abstract : HIV testing is recommended at time of cancer diagnosis, HBV and HCV screening because of the risk of reactivation with certain anticancer drugs.This is a cross-sectional study. The objectives were to assess the screening practices in cancer patients and the satisfaction of professionals in the event of use of the CancerHIV network. A questionnaire drafted by the CancerHIV expert and the OncoPaca-Corse Regional Cancer Network (RCN) was distributed in the region at the end of 2018 (part 1: V1) before being extended to the national level via the CancerHIV network (part 2: V2). Participation reached 160 and 130 respondents (V1 and V2, respectively). At the initial cancer assessment, 23% of respondents declared that they systematically screened for HIV at V1 (V2: 17%), 25% for HBV (V2: 20%) and 24% for HCV (V2: 19%). Before immunotherapy, the rates were 54% for HIV in V1 (V2: 52%), 57% for HBV (V2: 60%) and 55% for HCV (V2: 57%). Among the respondents, satisfaction when requesting a regional or national remedy was high (almost 100%). Screening for HIV, HBV and HCV allows supervised prescription of immunosuppressive or cytotoxic treatment to a potentially immunosuppressed patient. This study, resulting of an original collaboration between a RCN and a national expert network, underlines the lack of screening at the 2 examined stages of patient care, and the need for raising practitioners' awareness to recommendations.
Document type :
Journal articles
Complete list of metadata
Contributor : Odile Malbec Connect in order to contact the contributor
Submitted on : Friday, September 3, 2021 - 4:47:42 PM
Last modification on : Friday, May 20, 2022 - 11:06:35 AM
Long-term archiving on: : Saturday, December 4, 2021 - 8:00:46 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document



Myriam Taouqi, Marianne Veyri, Sylvie Brégigeon, Michèle Pibarot, Caroline Solas, et al.. [Survey on HIV, HBV and HCV screening practices in cancerology, France]. Bulletin du Cancer, John Libbey Eurotext, 2021, 108 (4), pp.369 - 376. ⟨10.1016/j.bulcan.2020.11.019⟩. ⟨inserm-03334396⟩



Record views